Platelet Rich Plasma Market Size is Anticipated to Hit US$ 708.64 Million by 2030

According to Precedence Research, the platelet rich plasma market size is forecasted to reach around US$ 708.64 million by 2030, growing at a 11.6% CAGR from 2021 to 2030.

Platelet rich plasma signifies a comparatively novel method in regenerative medicine. It is extracted from patient’s blood and comprises numerous growth factors and other essential biomolecules for wound curing. As there are numerous protocols for PRP formulating, it typically results with PRP generation with diverse amounts of bioactive substances, which eventually modify the concentration of wound curing. PRP also be utilized to advance healing after surgery for certain injuries. For instance, an athlete with an entirely torn heel cord may need surgery to repair the tendon. Curing of the torn tendon can probably be enhanced by treating the wounded area with PRP throughout surgery. This is completed by making the PRP in a distinct manner that permits it to essentially be stitched into torn tissues.

The capability of PRP to deliver enormous amounts of growth factors and numerous proteins, which are capable to encourage the healing procedure, signifies the vital influence for prevalent clinical application. In dissimilar tissues, comprising the musculoskeletal, healing procedure takes a long period on account of sluggish cell turnover and inadequate blood supply. The usage of PRP accelerates the neovascularization and consequently upsurge and nutrients influx and the blood supply essential for cell regeneration in injured tissue.

Download Free Sample Copy with TOC, Graphs & List of Figures @ https://www.precedenceresearch.com/sample/1237

Platelet Rich Plasma Market Estimations Y-O-Y:

  • Market Size Was Valued In 2021: US$ 263.35  Million
  • Market Size Is Projected to Grow By 2022: US$ 293.65 Million
  • Market Size Is Projected to Grow By 2023: US$ 327.65 Million
  • Market Size Is Projected to Grow By 2024: US$ 365.42 Million
  • Market Size Is Projected to Grow By 2025: US$ 407.80 Million
  • Market Size Is Projected to Grow By 2026: US$ 455.21 Million
  • Market Size Is Projected to Grow By 2027: US$ 508.27 Million
  • Market Size Is Projected to Grow By 2028: US$ 567.66 Million
  • Market Size Is Projected to Grow By 2029: US$ 634.16 Million
  • Market Size Is Projected to Grow By 2030: US$ 708.64 Billion
  • Compound Annual Growth Rate (CAGR) from 2021 to 2030: 11.6 percent

Scope of the Platelet Rich Plasma Market

Report Highlights Details
Base Year 2021
Historic Data 2017 to 2021
Forecast Period 2021 to 2030
Segments Covered Product, Origin, Application, and Geography
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA)

Growth Factors

Rising elderly population and intensifying orthopedic conditions are probable to lift the growth of global platelet rich plasma market. As per data published by National Center for Biotechnology Information, more than 1.4 million people are recognized with fractures related to osteoporosis every year. Besides, escalating attentiveness associated to platelet rich plasma therapy for dental treatment is likely to boost the market expansion.

Research and Development in drug delivery system for platelet-rich bioactive molecules is anticipated to propose profitable development prospects for companies operational in the global platelet-rich plasma market. For example, in 2020, researchers from Czech Republic, Charles University, and Institute of Experimental Medicine of the Czech Academy of Sciences stated development of an easy delivery system to extend the effects of the bioactive molecules released by platelets.

PRP comprise 7 growth factors, and it can be employed for numerous treatments, including severe ligament, and muscle wounds, chronic tendon wounds, knee arthritis, surgery, pain and fractures. In orthopedics, the usage of PRP is likely to upsurge over the year to come. Due to cumulative elderly populace, incidence of doctor-diagnosed arthritis is predictable to surge suggestively within prediction period. The popularity of PRP is on the escalation, still its true efficiency is yet to be completely recognized. The PRP is extensively utilized in surgery to recover torn knee ligaments, like the anterior circulate ligament. The PRP eases the rapid curing of the tissue afterward surgical actions.

COVID-19 Impact:

The industrial report mentions the influence of the ongoing COVID-19 pandemic. The outbreak has caused disturbances in several industries and has hammered the logistics, resulting in delayed deliveries and cancellation of product demand. The platelet rich plasma report proficiently explains the resulting factors and concerns of manufacturers. Researchers have also well-explained how the producers and providers will tackle the ongoing epidemic and the key strategies to be adopted post-pandemic for turning their businesses back to normal.

Report Highlights

  • International market participants like Harvest, Cesca, Biomet and Arthrex are reinforcing their prevailing distribution networks to augment their market footprint and revenue share
  • Among different applications, Orthopedics segment help majority of the market share in terms of revenue in 2019. This is on account of the fact that number of orthopedic problems such as quadriceps, rotator cuff, Achilles tendon injuries, hamstring, and tennis elbow can be treated effectively with PRP

Regional Snapshots

North America gathered major revenue cut in the global platelet-rich plasma market due to occurrence of noteworthy players who are functioning in the field of PRP market. Broadening application ranges of platelet rich plasma in therapeutics and snowballing number of patients diagnosed with orthopedic illnesses are few influences accountable for the leading expansion of the market in this region.

Asia Pacific is anticipated to exhibit rapid growth throughout assessment duration. Cumulative number of cosmetic surgeries to improve facial features in nations such as Thailand, Korea, and India are projected to boost growth of the market in this region. Further, rise in outlay in health care infrastructure, economy development, huge pool of patients with rheumatology and orthopedic ailments in evolving nations such as India, China, Malaysia, and South Korea, and upsurge in per capita health care spending in the region are further flourishing the market prospects.

Key Players:

The platelet rich plasma market is consolidated with a major number of manufacturers. The company profiling of key players in the market includes major business strategies, company overview and revenues. In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report. Primary research represents a bulk of research efforts, supplemented by extensive secondary research.

Some of the prominent players in the platelet rich plasma market include:

  • Zimmer Biomet
  • Arthrex, Inc.
  • Harvest Technologies Corporation
  • Stryker Corporation
  • DePuy Synthes, Inc.
  • Cesca Therapeutics, Inc.
  • AdiStem Ltd.
  • Exactech Inc.
  • ISTO Biologics
  • Nuo Therapeutics

Market Segmentation

By Product

  • Leukocyte Rich PRP
  • Pure PRP
  • Leukocyte Rich Fibrin

By Origin

  • Allogeneic PRP
  • Autologous PRP
  • Homologous PRP

By Application

  • Cosmetic Surgery & Dermatology
  • Orthopedic Surgery
  • General Surgery
  • Ophthalmic Surgery
  • Neurosurgery
  • Other

Regional Segmentation

  • North America (U.S. and Canada)
  • Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
  • Latin America (Brazil and Rest of Latin America)
  • Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions& Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Platelet Rich Plasma Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

Chapter 5. COVID 19 Impact on Platelet Rich Plasma Market

5.1. Covid-19: Platelet Rich Plasma Industry Impact

5.2. Platelet Rich Plasma Business Impact Assessment: Covid-19

5.2.1. Services Challenges/Disruption

5.2.2. Market Trends and Platelet Rich Plasma Opportunities in the COVID-19 Landscape for Major Markets

5.3. Strategic Measures against Covid-19

5.3.1. Government Support and Initiative to Combat Covid-19

5.3.2. Proposal for Platelet Rich Plasma Market Players to deal with Covid-19 Pandemic Scenario

Chapter 6. Platelet Rich Plasma Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.1.1. Intensifying elderly population and mounting pervasiveness of orthopedic situtaions

6.1.1.2. Growing applications of platelet-rich plasma products in hair transplant and other cosmetic applications

6.1.2. Market Restraints

6.1.2.1. Restraint 1

6.1.3. Market Opportunities

6.1.3.1. Opportunity 1

6.1.3.2. Opportunity 2

Chapter 7. Global Platelet Rich Plasma Market: Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.1.1. Platelet Rich Plasma Market Revenue by Market Players (2015-2020)

7.1.1.2. Platelet Rich Plasma Market Revenue Market Share by Market Players (2015-2020)

7.1.2. Key Organic/Inorganic Strategies Adopted by Players

7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Product Innovation

7.1.2.2. Merger and Acquisition, Collaboration and Partnerships

7.1.3. Market Players Landscape

7.1.3.1. List of Product Type Suppliers

7.1.3.2. List of End-users

Chapter 8. Global Platelet Rich Plasma Market, By Product Type

8.1. Platelet Rich Plasma Market, by Component, 2017-2030

8.1.1. Leukocyte Rich PRP

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Pure PRP

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Leukocyte Rich Fibrin

8.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Platelet Rich Plasma Market, By Application

9.1. Platelet Rich Plasma Market, by Application, 2017-2030

9.1.1. Allogeneic PRP

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Autologous PRP

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Homologous PRP

9.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Platelet Rich Plasma Market, By End-user

10.1. Platelet Rich Plasma Market, by End-user, 2017-2030

10.1.1. Cosmetic Surgery & Dermatology

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Orthopedic Surgery

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. General Surgery

10.1.3.1. Market Revenue and Forecast (2017-2030)

10.1.4. Ophthalmic Surgery

10.1.4.1. Market Revenue and Forecast (2017-2030)

10.1.5. Neurosurgery

10.1.5.1. Market Revenue and Forecast (2017-2030)

10.1.6. Others

10.1.6.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Platelet Rich Plasma Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue Forecast by Product Type(2017-2030)

11.1.2. Market Revenue Forecast by Application (2017-2030)

11.1.3. Market Revenue Forecast by End-user (2017-2030)

11.1.4. U.S

11.1.4.1. Market Revenue Forecast (2017-2030)

11.1.5. Canada

11.1.5.1. Market Revenue Forecast (2017-2030)

11.2. Europe

11.2.1. Market Revenue Forecast by Product Type(2017-2030)

11.2.2. Market Revenue Forecast by Application (2017-2030)

11.2.3. Market Revenue Forecast by End-user (2017-2030)

11.2.4. UK

11.2.4.1. Market Revenue Forecast (2017-2030)

11.2.5. Germany

11.2.5.1. Market Revenue Forecast (2017-2030)

11.2.6. France

11.2.6.1. Market Revenue Forecast (2017-2030)

11.2.7. Rest of EU

11.2.7.1. Market Revenue Forecast (2017-2030)

11.3. Asia Pacific (APAC)

11.3.1. Market Revenue Forecast by Product Type(2017-2030)

11.3.2. Market Revenue Forecast by Application (2017-2030)

11.3.3. Market Revenue Forecast by End-user (2017-2030)

11.3.4. China

11.3.4.1. Market Revenue Forecast (2017-2030)

11.3.5. India

11.3.5.1. Market Revenue Forecast (2017-2030)

11.3.6. Japan

11.3.6.1. Market Revenue Forecast (2017-2030)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue Forecast (2017-2030)

11.4. LATAM

11.4.1. Market Revenue Forecast by Product Type(2017-2030)

11.4.2. Market Revenue Forecast by Application (2017-2030)

11.4.3. Market Revenue Forecast by End-user (2017-2030)

11.4.4. Brazil

11.4.4.1. Market Revenue Forecast (2017-2030)

11.4.5. Rest of LATAM

11.4.5.1. Market Revenue Forecast (2017-2030)

11.5. Middle East and Africa (MEA)

11.5.1. Market Revenue Forecast by Product Type(2017-2030)

11.5.2. Market Revenue Forecast by Application (2017-2030)

11.5.3. Market Revenue Forecast by End-user (2017-2030)

11.5.4. GCC

11.5.4.1. Market Revenue Forecast (2017-2030)

11.5.5. North Africa

11.5.5.1. Market Revenue Forecast (2017-2030)

11.5.6. South Africa

11.5.6.1. Market Revenue Forecast (2017-2030)

11.5.7. Rest of MEA

11.5.7.1. Market Revenue Forecast (2017-2030)

Chapter 12. Company Profiles

12.1. Zimmer Biomet

12.1.1. Company Overview, Business Information, Regional Presence

12.1.2. Product Portfolio Analysis

12.1.2.1. Product Details, Specification, Application

12.1.3. Revenue, Price, and Gross Margin (2015-2020)

12.1.4. Recent Developments and Strategies

12.2. Arthrex, Inc.

12.2.1. Company Overview, Business Information, Regional Presence

12.2.2. Product Portfolio Analysis

12.2.2.1. Product Details, Specification, Application

12.2.3. Revenue, Price, and Gross Margin (2015-2020)

12.2.4. Recent Developments and Strategies

12.3. Harvest Technologies Corporation

12.3.1. Company Overview, Business Information, Regional Presence

12.3.2. Product Portfolio Analysis

12.3.2.1. Product Details, Specification, Application

12.3.3. Revenue, Price, and Gross Margin (2015-2020)

12.3.4. Recent Developments and Strategies

12.4. Stryker Corporation

12.4.1. Company Overview, Business Information, Regional Presence

12.4.2. Product Portfolio Analysis

12.4.2.1. Product Details, Specification, Application

12.4.3. Revenue, Price, and Gross Margin (2015-2020)

12.4.4. Recent Developments and Strategies

12.5. DePuy Synthes, Inc.

12.5.1. Company Overview, Business Information, Regional Presence

12.5.2. Product Portfolio Analysis

12.5.2.1. Product Details, Specification, Application

12.5.3. Revenue, Price, and Gross Margin (2015-2020)

12.5.4. Recent Developments and Strategies

12.6. Cesca Therapeutics, Inc.

12.6.1. Company Overview, Business Information, Regional Presence

12.6.2. Product Portfolio Analysis

12.6.2.1. Product Details, Specification, Application

12.6.3. Revenue, Price, and Gross Margin (2015-2020)

12.6.4. Recent Developments and Strategies

12.7. AdiStem Ltd.

12.7.1. Company Overview, Business Information, Regional Presence

12.7.2. Product Portfolio Analysis

12.7.2.1. Product Details, Specification, Application

12.7.3. Revenue, Price, and Gross Margin (2015-2020)

12.7.4. Recent Developments and Strategies

12.8. Exactech Inc.

12.8.1. Company Overview, Business Information, Regional Presence

12.8.2. Product Portfolio Analysis

12.8.2.1. Product Details, Specification, Application

12.8.3. Revenue, Price, and Gross Margin (2015-2020)

12.8.4. Recent Developments and Strategies

12.9. ISTO Biologics

12.9.1. Company Overview, Business Information, Regional Presence

12.9.2. Product Portfolio Analysis

12.9.2.1. Product Details, Specification, Application

12.9.3. Revenue, Price, and Gross Margin (2015-2020)

12.9.4. Recent Developments and Strategies

12.10. Nuo Therapeutics

12.10.1. Company Overview, Business Information, Regional Presence

12.10.2. Product Portfolio Analysis

12.10.2.1. Product Details, Specification, Application

12.10.3. Revenue, Price, and Gross Margin (2015-2020)

12.10.4. Recent Developments and Strategies

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Purchase Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1237

Contact Us:         

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Precedence Research

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.